251 related articles for article (PubMed ID: 6442563)
61. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
Scharla SH; Grauer A; Ziegler R
Klin Wochenschr; 1991 Jan; 69(1):25-30. PubMed ID: 2016845
[TBL] [Abstract][Full Text] [Related]
62. Paget's disease of bone: diagnosis and management.
Kanis JA; Evanson JM; Russell RG
Metab Bone Dis Relat Res; 1981; 3(4-5):219-30. PubMed ID: 6220190
[TBL] [Abstract][Full Text] [Related]
63. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
[TBL] [Abstract][Full Text] [Related]
64. Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin.
Yap AS; Mortimer RH; Jacobi JM; Galligan JP; Perry-Keene DA; Khafagi FA
Horm Res; 1991; 36(1-2):70-4. PubMed ID: 1814803
[TBL] [Abstract][Full Text] [Related]
65. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
Bone; 1985; 6(2):69-72. PubMed ID: 2409999
[TBL] [Abstract][Full Text] [Related]
66. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
Alexandre C; Trillet M; Meunier P; Fischer C
Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
[TBL] [Abstract][Full Text] [Related]
67. Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.
Fenton AJ; Gutteridge DH; Kent GN; Price RI; Retallack RW; Bhagat CI; Worth GK; Thompson RI; Watson IG; Barry-Walsh C
Clin Endocrinol (Oxf); 1991 Mar; 34(3):197-204. PubMed ID: 2036728
[TBL] [Abstract][Full Text] [Related]
68. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
69. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
[TBL] [Abstract][Full Text] [Related]
70. Two cases of monostotic Paget's disease: effects of bisphosphonate.
Hoshiro M; Harada T; Iwai H; Miyatake T; Nishimura A; Ohno Y; Aoki N
Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
[TBL] [Abstract][Full Text] [Related]
71. [Human calcitonin in the treatment of symptomatic Paget's disease].
Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
[TBL] [Abstract][Full Text] [Related]
72. Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
Thiébaud D; Jaeger P; Burckhardt P
J Bone Miner Res; 1987 Feb; 2(1):45-52. PubMed ID: 3455156
[TBL] [Abstract][Full Text] [Related]
73. The treatment of Paget's bone disease with sodium ethidronate.
Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
[TBL] [Abstract][Full Text] [Related]
74. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
[TBL] [Abstract][Full Text] [Related]
75. [Etidronic acid therapy in Paget's disease of bone].
Holz G; Delling G; Ziegler R
Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505
[TBL] [Abstract][Full Text] [Related]
76. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
77. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
Papapoulos SE; Frolich M; Mudde AH; Harinck HI; vd Berg H; Bijvoet OL
J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
[TBL] [Abstract][Full Text] [Related]
78. Chronic treatment of Paget's disease of bone with synthetic human calcitonin.
Lang R; Milkman M; Jensen PS; Vignery AM
Yale J Biol Med; 1981; 54(5):355-65. PubMed ID: 7336766
[TBL] [Abstract][Full Text] [Related]
79. Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
Goldfield EB; Braiker BM; Prendergast JJ; Kolb FO
JAMA; 1972 Sep; 221(10):1127-9. PubMed ID: 4679000
[No Abstract] [Full Text] [Related]
80. Determinants of remission of Paget's disease of bone.
Patel S; Stone MD; Coupland C; Hosking DJ
J Bone Miner Res; 1993 Dec; 8(12):1467-73. PubMed ID: 8304048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]